SG2014013205A - Formulations of deoxycholic acid and salts thereof - Google Patents

Formulations of deoxycholic acid and salts thereof

Info

Publication number: SG2014013205A
Authority: SG; Singapore
Prior art keywords: formulations; salts; deoxycholic acid; deoxycholic; acid
Prior art date: 2011-08-23

Application number

SG2014013205A

Other languages

English (en)

Inventor

Robert Emil Hodge

Jeffrey Douglas Webster

Robert M Moriarty

Original Assignee

Kythera Biopharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-23

Filing date

2011-08-23

Publication date

2014-05-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45569726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG2014013205(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-08-23 Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc

2014-05-29 Publication of SG2014013205A publication Critical patent/SG2014013205A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

SG2014013205A 2011-08-23 2011-08-23 Formulations of deoxycholic acid and salts thereof SG2014013205A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2011/048806 WO2013028177A1 (en)	2011-08-23	2011-08-23	Formulations of deoxycholic acid and salts thereof

Publications (1)

Publication Number	Publication Date
SG2014013205A true SG2014013205A (en)	2014-05-29

Family

ID=45569726

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG2014013205A SG2014013205A (en)	2011-08-23	2011-08-23	Formulations of deoxycholic acid and salts thereof

Country Status (18)

Country	Link
JP (1)	JP5919597B2 (es)
KR (5)	KR20200013103A (es)
CN (3)	CN103826608A (es)
AU (3)	AU2011375432B2 (es)
BR (1)	BR112014000547B1 (es)
CA (1)	CA2842177C (es)
CR (1)	CR20140053A (es)
EA (1)	EA029305B1 (es)
IL (1)	IL230547A (es)
IN (1)	IN2014CN02188A (es)
MX (1)	MX350390B (es)
MY (1)	MY184277A (es)
NZ (1)	NZ620040A (es)
PH (2)	PH12014500240A1 (es)
SG (1)	SG2014013205A (es)
UA (1)	UA113522C2 (es)
WO (1)	WO2013028177A1 (es)
ZA (1)	ZA201401027B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8101593B2 (en)	2009-03-03	2012-01-24	Kythera Biopharmaceuticals, Inc.	Formulations of deoxycholic acid and salts thereof
US20120237492A1 (en)	2011-02-18	2012-09-20	Kythera Biopharmaceuticals, Inc.	Treatment of submental fat
JP2018532806A (ja) *	2015-11-04	2018-11-08	キセラバイオファーマシューティカルズインコーポレイテッド	デオキシコール酸およびその塩による蓄積脂肪の処置方法
KR101841193B1 (ko) *	2016-09-22	2018-03-22	이경락	저장성 지방 분해 조성물 및 그의 제조 방법
US20180078621A1 (en) *	2016-09-22	2018-03-22	Kyoung Lack Lee	Composition for hypotonic lipolysis and manufacturing method thereof
US20190314388A1 (en) *	2018-04-16	2019-10-17	Penmix Ltd.	Pharmaceutical composition containing deoxycholic acid
KR102172439B1 (ko) *	2018-12-05	2020-10-30	송미희	지방 분해용 조성물 및 이를 포함하는 주사제 조성물
KR102064864B1 (ko)	2019-02-08	2020-01-10	(주)제테마	국소 주사용 조성물
KR102111346B1 (ko) *	2019-08-20	2020-05-22	아영창	침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
KR20220026068A (ko)	2020-08-25	2022-03-04	강명범	지방 분해용 주사제 조성물
CN116617160A (zh) *	2023-07-25	2023-08-22	山东则正医药技术有限公司	水性混悬液及制备方法、冻干粉及应用、脂肪消减注射剂
CN118005707A (zh) *	2024-01-18	2024-05-10	山东省食品药品检验研究院	一种脱氧胆酸钠晶型a及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2754709B1 (fr)	1996-10-23	1999-03-05	Sanofi Sa	Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
RU2224523C2 (ru) *	1998-07-24	2004-02-27	Сео Хонг Ю	Водный раствор, содержащий желчную кислоту, и способ его получения
US6417179B1 (en) *	1998-10-13	2002-07-09	Craig G. Burkhart	Ear wax solution
US20050048126A1 (en) *	2000-12-22	2005-03-03	Barrett Rabinow	Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10361067A1 (de) *	2003-12-22	2005-07-14	Aventis Pharma Deutschland Gmbh	Medikamentöse Lipolyse von Fettansammlungen
DK1758590T3 (da)	2004-05-19	2011-11-21	Los Angeles Biomed Res Inst	Anvendelse af et detergent til ikke-kirurgisk fjernelse af fedt
US20060127468A1 (en)	2004-05-19	2006-06-15	Kolodney Michael S	Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) *	2004-05-19	2010-07-13	The Regents Of The University Of California	Methods and related compositions for reduction of fat
ATE550031T1 (de)	2005-06-06	2012-04-15	Univ Georgetown	Zusammensetzungen und verfahren für die lipomodellierung
TW201011755A (en)	2008-09-10	2010-03-16	Skymedi Corp	Flash memory system and its data recovery method
JP5420946B2 (ja) *	2009-03-23	2014-02-19	富士フイルム株式会社	胆汁酸を含むミノキシジル水性組成物
EP2645099A1 (en) *	2012-03-30	2013-10-02	Phares Pharmaceutical Research N.V.	Biorelevant compositions

2011
- 2011-08-23 BR BR112014000547-8A patent/BR112014000547B1/pt not_active IP Right Cessation
- 2011-08-23 AU AU2011375432A patent/AU2011375432B2/en active Active
- 2011-08-23 NZ NZ620040A patent/NZ620040A/en not_active IP Right Cessation
- 2011-08-23 KR KR1020207002722A patent/KR20200013103A/ko not_active Ceased
- 2011-08-23 KR KR1020187032491A patent/KR102034606B1/ko active Active
- 2011-08-23 KR KR1020147006855A patent/KR101751585B1/ko not_active Expired - Fee Related
- 2011-08-23 MY MYPI2014000197A patent/MY184277A/en unknown
- 2011-08-23 KR KR1020177016779A patent/KR101919269B1/ko active Active
- 2011-08-23 CA CA2842177A patent/CA2842177C/en active Active
- 2011-08-23 PH PH1/2014/500240A patent/PH12014500240A1/en unknown
- 2011-08-23 UA UAA201400641A patent/UA113522C2/uk unknown
- 2011-08-23 MX MX2014001495A patent/MX350390B/es active IP Right Grant
- 2011-08-23 IN IN2188CHN2014 patent/IN2014CN02188A/en unknown
- 2011-08-23 JP JP2014527128A patent/JP5919597B2/ja not_active Expired - Fee Related
- 2011-08-23 CN CN201180072842.2A patent/CN103826608A/zh active Pending
- 2011-08-23 WO PCT/US2011/048806 patent/WO2013028177A1/en active Application Filing
- 2011-08-23 CN CN201810403291.7A patent/CN108743522A/zh active Pending
- 2011-08-23 EA EA201490175A patent/EA029305B1/ru unknown
- 2011-08-23 KR KR1020197030233A patent/KR102073536B1/ko active Active
- 2011-08-23 SG SG2014013205A patent/SG2014013205A/en unknown
- 2011-08-23 CN CN201810400642.9A patent/CN108619089A/zh active Pending
2014
- 2014-01-20 IL IL230547A patent/IL230547A/en active IP Right Grant
- 2014-01-30 CR CR20140053A patent/CR20140053A/es unknown
- 2014-02-10 ZA ZA2014/01027A patent/ZA201401027B/en unknown
2016
- 2016-04-27 AU AU2016202661A patent/AU2016202661B2/en not_active Ceased
- 2016-06-16 PH PH12016501175A patent/PH12016501175A1/en unknown
2018
- 2018-04-23 AU AU2018202807A patent/AU2018202807B2/en not_active Ceased

Also Published As

Publication number	Publication date
IL230547A0 (en)	2014-03-31
PH12016501175B1 (en)	2017-12-11
ZA201401027B (en)	2017-09-27
JP2014524467A (ja)	2014-09-22
KR20200013103A (ko)	2020-02-05
BR112014000547A2 (pt)	2017-02-14
MX2014001495A (es)	2014-04-25
KR101751585B1 (ko)	2017-06-27
UA113522C2 (xx)	2017-02-10
MY184277A (en)	2021-03-30
CA2842177C (en)	2016-07-19
CN103826608A (zh)	2014-05-28
KR102034606B1 (ko)	2019-10-22
AU2016202661B2 (en)	2018-02-22
KR101919269B1 (ko)	2018-11-15
AU2018202807A1 (en)	2018-05-10
CN108619089A (zh)	2018-10-09
WO2013028177A1 (en)	2013-02-28
KR102073536B1 (ko)	2020-02-04
MX350390B (es)	2017-09-06
AU2016202661A1 (en)	2016-05-19
KR20170075016A (ko)	2017-06-30
JP5919597B2 (ja)	2016-05-18
AU2011375432B2 (en)	2016-02-04
IN2014CN02188A (es)	2015-05-29
EA201490175A1 (ru)	2014-06-30
IL230547A (en)	2017-02-28
CN108743522A (zh)	2018-11-06
NZ620040A (en)	2016-06-24
AU2018202807B2 (en)	2020-01-16
KR20190119677A (ko)	2019-10-22
AU2011375432A1 (en)	2014-02-06
PH12016501175A1 (en)	2017-12-11
CR20140053A (es)	2014-06-12
PH12014500240A1 (en)	2022-11-23
CA2842177A1 (en)	2013-02-28
KR20150000448A (ko)	2015-01-02
BR112014000547B1 (pt)	2021-11-09
EA029305B1 (ru)	2018-03-30
KR20180123734A (ko)	2018-11-19

Publication	Publication Date	Title
ZA201401027B (en)	2017-09-27	Formulations of deoxycholic acid and salts thereof
ZA201308086B (en)	2015-03-25	Derivatives of 1-anino-2-cyclopropylboronic acid
IL237638A0 (en)	2015-04-30	Heteroaryl c17 derivatives of olanolic acid and methods of using them
IL237639A0 (en)	2015-04-30	Alkanedial and alkanedial derivatives at the 17th carbon position of oleinolic acid and methods of using them
AP3268A (en)	2015-05-31	Co-crystals and salts of CCR3-inhibitors
IL236965B (en)	2019-03-31	Derivatives of 5-aminolevulinic acid and uses thereof
EP2619194A4 (en)	2014-09-10	CATECHIN FATTY ACID DERIVATIVES AND METHODS OF USE
ZA201209666B (en)	2013-07-31	Salts and polymorhs of dexrabeprazole
PT3305298T (pt)	2019-07-29	Formulação do ácido desoxicólico e seus sais
PL2702060T3 (pl)	2016-06-30	Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczne
ZA201401599B (en)	2015-08-26	Preparation of methacrylic acid
ZA201207945B (en)	2013-06-26	Salts of dexlansoprazole and their preparation
EP2751071A4 (en)	2015-09-30	Fatty Acid Amide, Compositions Thereof and Method of Use Therefor
EP2782902A4 (en)	2015-08-26	DERIVATIVES FROM PHENOXYISOBUTTERIC ACID
SG10201607013UA (en)	2016-10-28	Formulations of deoxycholic acid and salts thereof